Phase 3 study of Elamipretide in patients with primary mitochondrial myopathies
Phase of Trial: Phase III
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Elamipretide (Primary)
- Indications Mitochondrial myopathies
- Focus Therapeutic Use
- 23 Jun 2016 New trial record
- 17 Jun 2016 Accoding to Stealth Biotherapeutics media release, the United Mitochondrial Disease Foundation (UMDF) symposium and the broader advocacy community look forward to fully supporting this upcoming Phase 3 trial.
- 17 Jun 2016 Accoding to Stealth Biotherapeutics media release, company will initiate discussions with the FDA to develop this trial.